Table 1.
Clinical and imaging characteristics of study eyes
| L | A | G | LS | LOC | BCVA | OCT |
|---|---|---|---|---|---|---|
| OD | 64 | F | PS | S | 20/126 | Foveal thinning |
| OS | 64 | F | PS | ST | 20/160 | Foveal thinning |
| OD | 45 | F | P | SN | 20/20 | Compact Fovea |
| OS | 45 | F | P | ST | 20/32 | Compact Fovea |
| OS | 67 | F | PS | ST | 20/126 | Scarred CNVM |
| OD | 48 | F | P | S | 20/32 | Intraretinal fluid |
| OS | 52 | M | P | ST | 20/20 | CSCR |
| OS | 41 | M | P | ST | 20/20 | Intraretinal fluid |
| OD | 37 | M | P | S | 20/16 | Compact fovea |
| OS | 37 | M | P | S | 20/16 | Compact fovea |
| OD | 53 | M | P | S | 20/200 | Intraretinal fluid |
| OS | 53 | M | P | S | 20/20 | Compact fovea |
L- Laterality; A- Age in years; G- Gender; F- Female; M- Male; LS- Lens status; PS- Pseudophakic; P- Phakic; LOC- Location of the artifact with respect to fovea; S- Superior; ST- Superotemporal; SN- Superonasal; BCVA- Best-corrected visual acuity; OCT- Optical coherence Tomography; CNVM- Choroidal neovascular membrane; CSCR- Central serous chorioretinopathy